Keywords: GAVI Alliance, Cervical cancer, Vaccine funding, Developing countries, Merck & Co, Gardasi. GlaxoSmithKline, Cervarix

GAVI Alliance funds vaccines for cervical cancer in developing countries

Article | 08 February 2013

Print This

More than 180,000 girls in eight developing countries are set to receive protection against the leading cause of cervical cancer thanks ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in